Skip to main content

Opko Health Inc(OPK-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Opko Health Inc

4400 BISCAYNE BLVD.
MIAMI FL 33137 USA
P: 305-575-4100
F: 305-575-6016
http://www.opko.com

Profile

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.

Key Executives

NameTitle
Jane H. HsiaoChief Technology Officer/Director/Vice Chairman of the Board
Phillip FrostCEO/Chairman of the Board/Director
Steven D. RubinDirector/Executive VP, Divisional
Elias A. ZerhouniDirector/President/Vice Chairman of the Board
Gary J. NabelDirector/Other Executive Officer

More from The Globe